Abstract Respiratory syncytial virus (RSV) causes substantial morbidity and mortality across the lifespan. with the highest burden seen in infants and older adults. Recently approved immunizing agents. including long-acting neutralizing monoclonal antibodies and a maternal vaccine for passive immunization of newborns. https://spencertifieders.shop/product-category/suitcases/